RETATRUTIDE: ONE DETAILED REVIEW

The novel class of GLP-1 receptor agonist and GIP co-agonist medications, such as tirzepatide, semaglutide, and the newly introduced retatrutide, offer significant advances in diabetes treatment . While all three operate by influencing blood readings , they vary in their unique mechanisms of effe